Skip to main content
Lunai Bioworks Inc. logo

Lunai Bioworks Inc. — Investor Relations & Filings

Ticker · RENB ISIN · US29350E1047 US Professional, scientific and technical activities
Filings indexed 580 across all filing types
Latest filing 2020-12-16 Director's Dealing
Country US United States of America
Listing US RENB

About Lunai Bioworks Inc.

https://www.lunaibio.com

Lunai Bioworks Inc. is a pre-clinical stage biotechnology company that utilizes artificial intelligence for drug discovery and biodefense. The company focuses on pioneering safe and responsible generative biology to develop new therapies. By harnessing phenomics and AI, it aims to decode disease signals and translate them into treatments. Its proprietary Transformer Platform is designed to accelerate drug discovery processes. Lunai Bioworks develops medicines, diagnostics, and biodefense products, with a pipeline that includes programs for neurodegenerative conditions like Alzheimer's disease.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2020-12-16 English
FORM 4
Director's Dealing
2020-12-16 English
FORM 10-Q
Interim / Quarterly Report Q1 2021
2020-11-12 English
FORM 10-K/A
Annual Report FY 2020
2020-10-28 English
FORM 10-K
Annual Report FY 2020
2020-09-23 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated September 15, 2020, by Enochian Biosciences Inc. It specifically mentions in Item 7.01 Regulation FD Disclosure that an Investor Presentation is attached as Exhibit 99.1. The text states that the presentation is "furnished herewith" and incorporated by reference, but the document itself is a short current report (3753 characters) and does not contain the full presentation content. This matches the pattern of an announcement or filing of an investor presentation rather than the presentation itself. According to the rules, if a document is short and states that a report or presentation is attached or available, it should be classified as a Regulatory Filing (RNS) rather than the report type itself (IP). Therefore, the correct classification is Regulatory Filings (RNS) with high confidence.
2020-09-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.